Search research articles
Contact Us
Filters
Showing results (41-50 of 64) with videos related to
Page
of 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2017
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients
A Longhi, S S Bielack, R Grimer, et al.
ESMO Open
|
September 25, 2021
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>☆</sup>
N Gaspar, Q Campbell-Hewson, S Gallego Melcon, et al.
Blood
|
August 18, 2022
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML
Maike Roas, Binje Vick, Marc-André Kasper, et al.
Nature Medicine
|
May 31, 2026
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Martin Wermke, Sebastian Ochsenreither, Dirk Jaeger, et al.
Blood
|
June 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST
Maximilian Merz, Nico Gagelmann, Samih Smaili, et al.
Blood
|
October 17, 2021
Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress
Theresa Landspersky, Mehmet Saçma, Jennifer Rivière, et al.
Leukemia
|
March 25, 2026
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma
Johannes Waldschmidt, David Fandrei, Judith S Hecker, et al.
Nature Medicine
|
June 19, 2026
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Martin Wermke, Sebastian Ochsenreither, Dirk Jaeger, et al.
Bone Marrow Transplantation
|
January 16, 2026
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland
Linda Simon, Vladan Vucinic, Kai Rejeski, et al.
Leukemia
|
September 21, 2022
Compartment-specific mutational landscape of clonal hematopoiesis
Luise Hartmann, Judith S Hecker, Maja Rothenberg-Thurley, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 64) with videos related to
Sort By:
Page
of 7
European Journal of Cancer (Oxford, England : 1990)
|
February 8, 2017
Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients
A Longhi, S S Bielack, R Grimer, et al.
ESMO Open
|
September 25, 2021
Phase I/II study of single-agent lenvatinib in children and adolescents with refractory or relapsed solid malignancies and young adults with osteosarcoma (ITCC-050)<sup>☆</sup>
N Gaspar, Q Campbell-Hewson, S Gallego Melcon, et al.
Blood
|
August 18, 2022
Targeting FLT3 with a new-generation antibody-drug conjugate in combination with kinase inhibitors for treatment of AML
Maike Roas, Binje Vick, Marc-André Kasper, et al.
Nature Medicine
|
May 31, 2026
MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Martin Wermke, Sebastian Ochsenreither, Dirk Jaeger, et al.
Blood
|
June 12, 2025
Remission conversion drives outcomes after CAR T-cell therapy for multiple myeloma: a registry analysis from the DRST
Maximilian Merz, Nico Gagelmann, Samih Smaili, et al.
Blood
|
October 17, 2021
Autophagy in mesenchymal progenitors protects mice against bone marrow failure after severe intermittent stress
Theresa Landspersky, Mehmet Saçma, Jennifer Rivière, et al.
Leukemia
|
March 25, 2026
Flare of clonal hematopoiesis, TP53 expansion and prior melphalan drive post-CAR-T myeloid disorders in multiple myeloma
Johannes Waldschmidt, David Fandrei, Judith S Hecker, et al.
Nature Medicine
|
June 19, 2026
Author Correction: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial
Martin Wermke, Sebastian Ochsenreither, Dirk Jaeger, et al.
Bone Marrow Transplantation
|
January 16, 2026
Results of brexucabtagene-autoleucel for patients with relapsed/refractory Mantle Cell Lymphoma in the routine setting in Germany and Switzerland
Linda Simon, Vladan Vucinic, Kai Rejeski, et al.
Leukemia
|
September 21, 2022
Compartment-specific mutational landscape of clonal hematopoiesis
Luise Hartmann, Judith S Hecker, Maja Rothenberg-Thurley, et al.
Page
of 7